Getinib 250 Mg (Gefitinib) – 28 Tablets

Getinib 250 Mg (Gefitinib) marks a revolutionary breakthrough in cancer treatment, specifically in the context of non-small cell lung cancer (NSCLC). The active ingredient, Gefitinib, is a testament to cutting-edge science, offering a targeted and effective strategy for individuals confronting the challenges of this formidable disease.

Getinib 250 mg relies on Gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Its mechanism of action involves precisely blocking the signals responsible for promoting the growth of cancer cells.

Getinib 250 is primarily prescribed for:

• Non-Small Cell Lung Cancer (NSCLC): Specifically recommended for individuals with NSCLC, particularly those harboring specific EGFR mutations.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Getinib 250 Mg (Gefitinib) medicine.